Literature DB >> 34978650

Safety and efficacy of pterygium extended removal followed by extended conjunctival transplant for recurrent pterygia.

Waleed A Allam1,2, Ahmed Roshdy Alagorie3, Mohammed H Nasef1,2, Molham A El-Bakary1.   

Abstract

PURPOSE: To study the safety and efficacy of pterygium extended removal followed by extended conjunctival transplant for recurrent pterygia.
METHODS: Thirty-three eyes of 33 subjects with recurrent pterygia were enrolled in this prospective case series study. Pterygium extended removal followed by extended conjunctival transplantation was performed in all subjects. One surgeon (WA) performed all surgeries. All subjects completed follow-up for at least 12 months and were evaluated for recurrence and complications.
RESULTS: The mean age of the participants was 41.2 ± 10.3 years (range 22-60), 7 females (21.2%). The mean duration of follow-up was 25.64 ± 9.24 months (range 12-43). Corrected distance visual acuity (decimal notation) improved from 0.69 ± 0.22 (range 0.2-1.0) at presentation to a 1-year postoperative value of 0.83 ± 0.2 (range 0.3-1.0). No recurrence was reported in all subjects throughout the follow-up period. Transient graft swelling was recorded in 14 cases (42.4%) and resolved in all cases by the first week. All patients developed variable degrees of transient postoperative diplopia that resolved completely by the first 6 weeks. Donor site granuloma developed in 4 cases (12.1%). Spontaneous resolution was observed in 3 cases, while in one case, surgical excision was performed 2 months after the procedure.
CONCLUSIONS: In this study of eyes with recurrent pterygia, pterygium extended removal followed by extended conjunctival transplant was found safe and effective with no recurrence and minimal postoperative complications.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  PERFECT for PTERYGIUM®; Recurrent pterygium

Mesh:

Year:  2022        PMID: 34978650     DOI: 10.1007/s10792-021-02199-w

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.029


  23 in total

1.  Evaluating pterygium severity: a survey of corneal specialists.

Authors:  J D Twelker; I L Bailey; M J Mannis; W A Satariano
Journal:  Cornea       Date:  2000-05       Impact factor: 2.651

2.  Quantification of Astigmatism Induced by Pterygium Using Automated Image Analysis.

Authors:  Sang Beom Han; Hyun Sun Jeon; Moosang Kim; Seung-Jun Lee; Hee Kyung Yang; Jeong-Min Hwang; Kwang Gi Kim; Joon Young Hyon; Won Ryang Wee
Journal:  Cornea       Date:  2016-03       Impact factor: 2.651

3.  Comparison of conjunctival autograft with amniotic membrane transplantation for pterygium surgery: surgical and cosmetic outcome.

Authors:  Cem Küçükerdönmez; Yonca A Akova; Dilek Dursun Altinörs
Journal:  Cornea       Date:  2007-05       Impact factor: 2.651

Review 4.  Options and adjuvants in surgery for pterygium: a report by the American Academy of Ophthalmology.

Authors:  Stephen C Kaufman; Deborah S Jacobs; W Barry Lee; Sophie X Deng; Mark I Rosenblatt; Roni M Shtein
Journal:  Ophthalmology       Date:  2012-10-11       Impact factor: 12.079

5.  Comparison of amniotic membrane graft alone or combined with intraoperative mitomycin C to prevent recurrence after excision of recurrent pterygia.

Authors:  David Hui-Kang Ma; Lai-Chu See; Yih-Shiou Hwang; Su-Fang Wang
Journal:  Cornea       Date:  2005-03       Impact factor: 2.651

6.  Pterygium recurrence time.

Authors:  L W Hirst; A Sebban; D Chant
Journal:  Ophthalmology       Date:  1994-04       Impact factor: 12.079

7.  Randomized controlled trial of subconjunctival bevacizumab injection in impending recurrent pterygium: a pilot study.

Authors:  Kaevalin Lekhanont; Thanikan Patarakittam; Prakairut Thongphiew; Olan Suwan-apichon; Prut Hanutsaha
Journal:  Cornea       Date:  2012-02       Impact factor: 2.651

8.  Amniotic membrane transplantation with conjunctival autograft for recurrent pterygium.

Authors:  Jun Shimazaki; Koichi Kosaka; Shigeto Shimmura; Kazuo Tsubota
Journal:  Ophthalmology       Date:  2003-01       Impact factor: 12.079

9.  Topical application of bevacizumab as an adjunct to recurrent pterygium surgery.

Authors:  Engin B Ozgurhan; Alper Agca; Necip Kara; Kemal Yuksel; Ali Demircan; Ahmet Demirok
Journal:  Cornea       Date:  2013-06       Impact factor: 2.651

10.  Single and multiple injections of subconjunctival ranibizumab for early, recurrent pterygium.

Authors:  Volkan Hurmeric; Pravin Vaddavalli; Anat Galor; Victor L Perez; Janika San Roman; Sonia H Yoo
Journal:  Clin Ophthalmol       Date:  2013-03-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.